SXI Life Sciences
7.288,53
PKT
+69,99
PKT
+0,97
%
Werbung
Analysen zu SXI Life Sciences-Werten
Datum | Rating | Analyst | |
---|---|---|---|
05.06.15 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
04.06.15 | Novartis buy | Citigroup Corp. | |
02.06.15 | Roche overweight | JP Morgan Chase & Co. | |
02.06.15 | Novartis overweight | JP Morgan Chase & Co. | |
22.05.15 | Roche buy | UBS AG | |
21.05.15 | Novartis buy | Jefferies & Company Inc. | |
21.05.15 | Roche buy | Jefferies & Company Inc. | |
21.05.15 | Novartis buy | Citigroup Corp. | |
21.05.15 | Novartis overweight | JP Morgan Chase & Co. | |
18.05.15 | Roche buy | UBS AG | |
15.05.15 | Roche buy | Goldman Sachs Group Inc. | |
14.05.15 | Roche overweight | JP Morgan Chase & Co. | |
13.05.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
12.05.15 | Novartis buy | Citigroup Corp. | |
30.04.15 | BB Biotech accumulate | equinet AG | |
29.04.15 | Roche buy | Merrill Lynch & Co., Inc. | |
29.04.15 | Roche overweight | JP Morgan Chase & Co. | |
29.04.15 | Novartis buy | Citigroup Corp. | |
29.04.15 | Roche Neutral | Citigroup Corp. | |
28.04.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
24.04.15 | Novartis Hold | Deutsche Bank AG | |
24.04.15 | Novartis Outperform | Credit Suisse Group | |
24.04.15 | Roche Neutral | UBS AG | |
23.04.15 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
23.04.15 | Novartis buy | S&P Capital IQ | |
22.04.15 | Roche Hold | S&P Capital IQ | |
22.04.15 | Roche kaufen | Independent Research GmbH | |
21.04.15 | Novartis Outperform | BNP PARIBAS | |
21.04.15 | Roche Outperform | Bernstein Research | |
21.04.15 | Novartis Outperform | Bernstein Research | |
21.04.15 | Roche Neutral | UBS AG | |
20.04.15 | BB Biotech buy | Oddo Seydler Bank AG | |
20.04.15 | BB Biotech Verkaufen | Independent Research GmbH | |
17.04.15 | Roche buy | Deutsche Bank AG | |
16.04.15 | Novartis Hold | Société Générale Group S.A. (SG) | |
16.04.15 | Roche buy | Société Générale Group S.A. (SG) | |
14.04.15 | Novartis neutral | Independent Research GmbH | |
14.04.15 | Novartis overweight | JP Morgan Chase & Co. | |
14.04.15 | Novartis buy | UBS AG | |
13.04.15 | Novartis buy | Jefferies & Company Inc. |